"We are incredibly grateful for Dr. Russell's many years of leadership at Sabin and I look forward to continuing to work with him. Mort Hyman's election as board chair comes at an opportune time as we expand our activities into multi-dimensional aspects of neglected tropical and other infectious diseases. Sabin is fortunate to have the leadership of these two highly distinguished individuals, particularly as we move forward with our Global Network for Neglected Tropical Diseases. This initiative, sponsored by the Bill & Melinda Gates Foundation, works to provide access to essential medicines for people suffering from seven devastating neglected tropical diseases (NTDs)," said Dr.
Mr. Hyman brings to Sabin extensive experience in leadership of philanthropic, business and governmental organizations. For over 30 years, he served as President and a director of Overseas Shipholding Group, a NYSE-listed company that owns and operates one of the world's largest fleet of oil tankers. He retired from the company in 2003 as chairman of the board and CEO. He also served as vice chairman of a major Swiss private bank and as president of its affiliated investment companies until his retirement in 2003, at which time he founded MPH Enterprises, LLC, a private equity investor.
Mr. Hyman noted, "I look forward to working with Sabin's outstanding Board and staff in its efforts to eliminate the scourge of NTDs. These diseases, which cause debilitating illness and sometimes death, affect not only the health of the world's poorest populations, they also dramatically and adversely affect a child's ability to learn in school, and an adult's ability to work productively. We can make an important change in the lives of so many. In 2007 alone, the Global Network's members provided treatment for 150 million people, at a cost of less than
Mr. Hyman's experience in the public health arena will benefit Sabin as it builds awareness of NTDs and infectious diseases around the world. In 1971, Mr. Hyman began making his mark in the public health sector with his appointment by Governor
In 1973, Mr. Hyman joined the Board of Trustees of Beth Israel Medical Center in
Mr. Hyman continues to serve on the boards of the Albert Einstein College of Medicine, the N.Y. Academy of Medicine and the N.Y. Academy of Sciences. Mr. Hyman graduated with distinction from the
In recognition of his leadership, commitment and dedication, Mr. Hyman has received numerous awards, including an honorary Doctor of Humane Letters (honoris causa) from
About Sabin Vaccine Institute
Sabin Vaccine Institute (Sabin) is a biomedical, science-driven organization dedicated to reducing human suffering from infectious and neglected tropical diseases (NTDs). A pioneer in the fight against NTDs, which affect over one billion people each year, Sabin and the members of the Global Network for Neglected Tropical Diseases, are providing low cost drug therapies to millions in need. Through a robust R&D program, in partnership with The
SOURCE Sabin Vaccine Institute